Abbott Labs Wins FDA Approval For MitraClip Implant

Law360, New York (October 25, 2013, 5:35 PM EDT) -- Abbott Laboratories won the green light from U.S. medical device regulators for its MitraClip implantable heart device, which is marketed as a less invasive way to treat heart valve defects, the health care products giant said Friday. 

The U.S. Food and Drug Administration has approved the MitraClip treatment, which would be among of the first of its kind of device sold in the U.S., for patients with serious mitral regurgitation — a health condition where the mitral valve doesn't fully close — and for whom surgery...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.